Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

735.20
+0.39000.05%
Post-market: 737.802.60+0.35%17:29 EDT
Volume:613.94K
Turnover:451.26M
Market Cap:75.69B
PE:18.18
High:742.50
Open:740.50
Low:729.20
Close:734.81
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.69
T/O Rate:0.62%
Dividend:3.64
Dividend Rate:0.50%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.39
PE(LYR):17.72

Loading ...

Regeneron Pharmaceuticals (REGN) Posts Strong Q2 Revenue, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 03

Regeneron price target raised to $740 from $700 at Citi

TIPRANKS
·
Aug 03

Biocon Launches Yesafili Biosimilar to Regeneron’s Eylea in US

Reuters
·
Aug 03

Weekly Winners | Microsoft Rockets 22%; Garmin Soars 21%; Amazon, Chipotle Jump 17% Each; Regeneron Pharmaceuticals Gains 16%

Tiger Newspress
·
Aug 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.09% in Regular Trading, Q2 Earnings Beat Continues to Drive Stock Higher

Market Focus
·
Aug 01

Regeneron Announces Q3 2026 Distribution of R$ 0.05 Per Unit

Reuters
·
Jul 31

Regeneron Pharmaceuticals' Robust Q2 Sales Amid Limited Spend Increases to Help Ramp H2 Margins, RBC Says

MT Newswires Live
·
Jul 31

Regeneron Pharma is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Regeneron (REGN) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 31

Regeneron price target raised to $795 from $750 at Cantor Fitzgerald

TIPRANKS
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

GlobeNewswire
·
Jul 31

Morgan Stanley Adjusts PT on Regeneron Pharmaceuticals to $758 From $730, Keeps Equalweight Rating

MT Newswires Live
·
Jul 31

Regeneron Pharmaceuticals Inc : JP Morgan Raises Target Price to $900 from $850

THOMSON REUTERS
·
Jul 31

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Stock Track | Regeneron Pharmaceuticals Soars 5.79% in Intraday Trading After Q2 Earnings Crush Estimates on Dupixent and Eylea HD Strength

Stock Track
·
Jul 31

Regeneron Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30